Discover how AI-integrated medical devices are transforming healthcare by 2025 and beyond with advanced technologies and improved accessibility.

Riliprubart Earns Orphan Drug Designation in the US for Antibody-mediated Rejection in Solid Organ Transplantation This designation reflects Sanofi’s commitment to addressing a critical unmet need in ...

Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted De Novo ...

Nursing is a vital component of the healthcare sector. Nurses play a critical role in healthcare delivery. Their part in the medical care industry has become increasingly significant. They are ...

Orphalan collaborates with MAP International to provide life-changing medicine for Wilson disease in underserved communities.

Discover how Nasal Spray LUCA V creates a protective barrier against viruses and allergies without medications.

Avio Health, a deep-tech company dedicated to advancing healthcare through data analytics and machine learning, today announced the launch of the world’s first Functional Medicine-based Large Language ...

Genome Canada funds ClarityDX Prostate test to enhance prostate cancer diagnostics in Canadian healthcare.

Discover how the FDA's De Novo clearance boosts treatment options for complex cardiovascular conditions with this innovative peripheral retrievable stent system.

Median Technologies submits application for eyonis® LCS, aiming for U.S. clearance by Q3 2025 after successful pivotal studies.

Study shows Black patients face stigmatizing language in labor and delivery notes compared to White patients, highlighting bias.

Discover how guided spinal navigation enhances surgery with cost-effective 3D augmented reality for healthcare professionals.